A detailed history of Truvestments Capital LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Truvestments Capital LLC holds 21,821 shares of ABBV stock, worth $3.7 Million. This represents 1.19% of its overall portfolio holdings.

Number of Shares
21,821
Previous 19,739 10.55%
Holding current value
$3.7 Million
Previous $3.39 Million 27.3%
% of portfolio
1.19%
Previous 1.38%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$163.84 - $199.33 $341,114 - $415,005
2,082 Added 10.55%
21,821 $4.31 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $33,125 - $38,682
214 Added 1.1%
19,739 $3.39 Million
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $1.01 Million - $1.15 Million
6,317 Added 47.83%
19,525 $3.56 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $203,785 - $229,510
1,481 Added 12.63%
13,208 $2.05 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $65,459 - $75,778
490 Added 4.36%
11,727 $1.75 Million
Q2 2023

Aug 10, 2023

BUY
$132.51 - $164.9 $122,969 - $153,027
928 Added 9.0%
11,237 $1.51 Million
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $186,836 - $215,169
-1,292 Reduced 11.14%
10,309 $1.64 Million
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $1.61 Million - $1.93 Million
-11,620 Reduced 50.04%
11,601 $1.88 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $139,712 - $160,241
1,041 Added 4.69%
23,221 $3.12 Million
Q2 2022

Aug 09, 2022

BUY
$137.62 - $174.96 $26,973 - $34,292
196 Added 0.89%
22,180 $3.4 Million
Q1 2022

May 02, 2022

SELL
$131.98 - $163.75 $1,055 - $1,310
-8 Reduced 0.04%
21,984 $3.56 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $53,177 - $67,285
495 Added 2.3%
21,992 $2.98 Million
Q3 2021

Oct 29, 2021

BUY
$106.4 - $120.78 $91,184 - $103,508
857 Added 4.15%
21,497 $2.32 Million
Q2 2021

Aug 12, 2021

BUY
$105.21 - $117.21 $128,040 - $142,644
1,217 Added 6.27%
20,640 $2.33 Million
Q1 2021

May 18, 2021

BUY
$102.3 - $112.62 $216,569 - $238,416
2,117 Added 12.23%
19,423 $2.1 Million
Q4 2020

Feb 17, 2021

BUY
$80.49 - $108.67 $56,182 - $75,851
698 Added 4.2%
17,306 $1.85 Million
Q3 2020

Nov 13, 2020

SELL
$85.91 - $100.83 $234,534 - $275,265
-2,730 Reduced 14.12%
16,608 $1.45 Million
Q2 2020

Aug 06, 2020

SELL
$73.37 - $98.18 $138,742 - $185,658
-1,891 Reduced 8.91%
19,338 $1.9 Million
Q1 2020

May 07, 2020

BUY
$64.5 - $97.79 $32,959 - $49,970
511 Added 2.47%
21,229 $1.62 Million
Q4 2019

Jan 29, 2020

BUY
$72.13 - $90.25 $83,093 - $103,968
1,152 Added 5.89%
20,718 $1.83 Million
Q3 2019

Oct 10, 2019

BUY
$62.98 - $75.72 $297,454 - $357,625
4,723 Added 31.82%
19,566 $1.48 Million
Q2 2019

Jul 15, 2019

BUY
$65.7 - $83.98 $498,991 - $637,828
7,595 Added 104.79%
14,843 $1.08 Million
Q1 2019

Apr 12, 2019

SELL
$77.14 - $90.79 $560,344 - $659,498
-7,264 Reduced 50.06%
7,248 $584,000
Q3 2018

Oct 22, 2018

BUY
$88.91 - $98.84 $41,165 - $45,762
463 Added 3.3%
14,512 $1.37 Million
Q2 2018

Aug 28, 2018

BUY
$89.78 - $106.23 $1.26 Million - $1.49 Million
14,049 New
14,049 $1.3 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $300B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Truvestments Capital LLC Portfolio

Follow Truvestments Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Truvestments Capital LLC with notifications on news.